2d
Zacks Investment Research on MSNENZ Stock Down Following Q2 Earnings, Revenues Decline Y/YShares of Enzo Biochem, Inc. ENZ have lost 0.7% since the company reported its earnings for the quarter ended Jan. 31, 2025.
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results